Efficacy and Safety of Botulinum Toxin Type B (Myobloc®) for the Treatment of Sialorrhea in Parkinson's Disease (PD)

被引：0
|
作者：
Salazar-Grueso, Edgar F.
Hogan, Patrick
Pagan, Fernando
Reinhard, Sharon
Pappert, Eric
Birmingham, William
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A26 / A26
页数：1
相关论文
共 50 条
  • [21] Botulinum toxin type B (Myobloc®):: Pharmacology and biochemistry
    Callaway, JE
    CLINICS IN DERMATOLOGY, 2004, 22 (01) : 23 - 28
  • [22] Botulinum toxin type a as a complementary treatment in Parkinson's disease
    Porta, M
    Camerlingo, M
    Maggioni, G
    Perretti, A
    Dell'Anna, E
    Ferrante, C
    MOVEMENT DISORDERS, 2002, 17 : S99 - S99
  • [23] Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Caline Nobrega, Ana
    Rodrigues, Bernardo
    Catarina Torres, Ana
    Enzo, Alfredo
    Melo, Ailton
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 253 (1-2) : 85 - 87
  • [24] Pediatric adverse events with botulinum toxin type B (MYOBLOC): A review of the safety database
    Royal, M
    Leong, M
    ANNALS OF NEUROLOGY, 2005, 58 : S35 - S35
  • [25] Sialorrhea in Patients with Parkinson's Disease: Safety and Administration of Botulinum Neurotoxin
    Egevad, Gustav
    Petkova, Valentina Yankova
    Vilholm, Ole Jakob
    JOURNAL OF PARKINSONS DISEASE, 2014, 4 (03) : 321 - 326
  • [26] A double-blind, randomised, placebo-controlled study to evaluate efficacy and safety of botulinum toxin type b (myobloc/neurobloc) and botulinum toxin type A (dysport) for the treatment of spastic paraparesis
    Mancini, F
    Moglia, A
    Allena, M
    Sandrini, G
    Nappi, G
    Pacchetti, C
    MOVEMENT DISORDERS, 2004, 19 : S127 - S127
  • [27] Long-term Safety and Efficacy Data on Botulinum Toxin Type A An Injection for Sialorrhea
    Chan, Kenny H.
    Liang, Conan
    Wilson, Pamela
    Higgins, David
    Allen, Gregory C.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2013, 139 (02) : 134 - 138
  • [28] Botulinum toxin type B (Myobloc™) in refractory myofascial pain
    Royal, M
    Adams, D
    Jenson, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R37 - R37
  • [29] Botulinum toxin type B for gait freezing in Parkinson's disease
    Fernandez, HH
    Lannon, MC
    Trieschmann, ME
    Friedman, JH
    MEDICAL SCIENCE MONITOR, 2004, 10 (07): : CR282 - CR284
  • [30] Botulinum toxin type B for gait freezing in Parkinson's disease
    Fernandez, HH
    Lannon, MC
    Trieschmann, ME
    Friedman, JH
    MOVEMENT DISORDERS, 2003, 18 (09) : 1090 - 1090
12345